Targeted nanoimmunotherapy reduces atherosclerotic plaque burden in mice
This new article publication from Acta Pharmaceutica Sinica B discusses a targeted nanoimmunotherapy designed to restore macrophage clearance of dying cells, promote an anti-inflammatory phenotype, and reduce atherosclerotic plaque burden in mice.
Read original article on The Medical News →Related news
-
Comprehensive genetic map offers new hope for tuberculosis treatments
United Kingdom
-
New CRISPR proteins expand editing access to heart disease genes
United Kingdom
-
Pulse oximeter bias undercounts sleep apnea severity in Black patients
United Kingdom
-
Deep learning method maps spatial architecture of brain cancer cells
United Kingdom
-
Key gene preserves lifelong supply of stem cells that make bone healing possible, study suggests
United Kingdom
-
Rapid tau spread may explain why midlife Alzheimer's progresses more rapidly
United Kingdom
-
Experimental ultrasound implant could help guide care after spinal cord injury
United Kingdom
-
From green smoothies to stem‑cell supplements—online 'immune‑boosting' ideas may lead you astray
United Kingdom